Psychopharmacology in the Pediatric Oncology and Bone Marrow Transplant Units: Antidepressant Treatment,Journal of Child and Adolescent Psychopharmacology

当前位置： X-MOL 学术 › J. Child Adolesc. Psychopharmacol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Psychopharmacology in the Pediatric Oncology and Bone Marrow Transplant Units: Antidepressant Treatment
Journal of Child and Adolescent Psychopharmacology ( IF 1.5 ) Pub Date : 2022-04-18 , DOI: 10.1089/cap.2021.0083
Orly Lavan _{1,

2} , Orit Peled _{2,

3} , Meital Avishai-Neumann _{1,

2} , Abraham Weizman _{2,

4} , Anat Yahel _{2,

5} , Alan Apter _{1,

2} , Avi Valevski _{2,

4} , Silvana Fennig _{1,

2} , Jerry Stein _{2,

5} , Noa Benaroya-Milshtein _{2,

3}

Affiliation

Objectives: The aim of this study was to characterize the clinical profiles, tolerability, and efficacy of two groups of antidepressants, selective serotonin reuptake inhibitors (SSRIs), and the atypical antidepressant, mirtazapine, in children and adolescents treated in a large pediatric Hematology–Oncology center.

中文翻译：